Skip to main content
. 2022 Mar 2;13(3):6688–6697. doi: 10.1080/21655979.2022.2026553

Figure 5.

Figure 5.

Memantine mitigated oxaliplatin-induced alteration in the ratio of Bax/Bcl-2. Cells were treated with oxaliplatin at 50 μM and Memantine at 5 and 10 µM for 24 hours. (a). Protein expression of Bax and Bcl-2; (b). Statistical analysis of Bax/Bcl-2 (n = 5, **, P < 0.01 vs. vehicle group; #, ##, P < 0.05, 0.01 vs. oxaliplatin group).